# Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236

> **NCT00767052** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** AZD1236
- **DRUG:** Placebo
- **DRUG:** AZD1236
- **DRUG:** AZD1236

## Key facts

- **NCT ID:** NCT00767052
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2009-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767052, "Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00767052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*